That decision is always made with your clinician, not on your own
Three peptides get the most attention in orthopedic and sports medicine: BPC-157 (Body Protection Compound-157), TB-500 (a synthetic fragment of Thymosin Beta-4), and GHK-Cu (a copper-binding tripeptide)
Its newer, so theres still a lot being studied, but the buzz around it is growing
In our practice, tirzepatide is the medication I reach for first when a patients goal is meaningful weight loss (more than 10 to 15 percent of body weight) and their clinical picture supports it
Comparative analysis of long-term outcomes of torasemide and furosemide in heart failure patients in heart failure registries of the European society of cardiology
This is particularly important because body fat mass is associated with adverse health outcomes in obesity, whereas lean body mass is generally considered to be non-risk increasing and even protective